Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, often results in the need for renal replacement therapy, and is the etiology
[...]More than 26 million Americans are affected by chronic kidney disease (CKD), and the prevalence of CKD is increasing. In addition, there is growing evidence that minority
[...]World Kidney Day (WKD), established in 2006, is an initiative to raise awareness about the health burden of kidney disease. The theme for World Kidney Day 2019 is global
[...]Editors’ Note: We are always happy to see the implementation of research published in AJKD. Please see below for a description of a bedside tool developed to help
[...]In late 2009, the primary results of the placebo-controlled Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) were published. TREAT randomized 4,038 patients
[...]Over the last few years, the management of hepatitis C has been revolutionized by the advent of direct antiviral agents (DAA). This has arguably been one of the most
[...]Discussion about renal replacement therapy selection in our patients with CKD is complex, but an important part of any nephrology practice. If we know the patient well, it
[...]The history of epilepsy is a tale full of mysticism and superstition. It was first described in 2000 BCE by the Mesopotamians as antasubbu, or “hand of sin.” The Akkadian
[...]A recent study published in AJKD by Dhondup et al provides a number of helpful insights into the progression of kidney disease in patients with nephrolithiasis. Although the
[...]The significant adverse effects on both morbidity and mortality of a tunneled dialysis catheter (TDC) are well-known. Despite these known adverse outcomes, 80% of patients in
[...]
